CCM
CEREW

Context Capital Management’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Context Capital Management’s Portfolio CEREW Stock Details CEREW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-62,668
Closed -$902K – 593
2021
Q2 		$902K Sell
62,668
-20,200
-24% -$101K 0.08% 252
2021
Q1 		$357K Sell
82,868
-3,099
-4% -$14K 0.04% 316
2020
Q4 		$486K Buy
+85,967
New +$347K 0.07% 169

Context Capital Management's CEREW Position: Q3 2021 in Review

Context Capital Management sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 62,668 shares — an estimated $902K sold.

Context Capital Management first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $902K in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

  • Context Capital Management reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
  • Context Capital Management sold 62,668 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $902K.
  • Context Capital Management first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
  • Context Capital Management's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $902K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Context Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.